α-1,3-fucosyltransferase-VII stimulates the growth of hepatocarcinoma cells via the cyclin-dependent kinase inhibitor p27Kip1

Cellular and Molecular Life Sciences

Volumn 62, Issue 2, 2005, Pages 171-178

  Wang, Q Y ^a   Guo, P ^a   Duan, L L ^a   Shen, Z H ^a   Chen, H L ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

1,3 Fucosyltransferase (FucT) VII; Cyclin dependent kinase (CDK); Cyclin dependent kinase inhibitor (CDI); p27Kip1; Retinoblastoma (Rb) protein; Sialyl Lewis X

Indexed keywords

ALPHA 1,3 FUCOSYLTRANSFERASE; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MEMBRANE ANTIGEN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P16INK4A; RETINOBLASTOMA PROTEIN; SIALYL LEWIS X ANTIGEN;

ARTICLE; CANCER GROWTH; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOWN-REGULATION; FUCOSYLTRANSFERASES; HUMANS; LIVER NEOPLASMS; MICE; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 13244281681     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-4349-8     Document Type: Article

References (32)

1. Narimatsu H. (1998) Human fucosyltransferases: tissue distribution of blood group antigens, cancer associated antigens and fucosyltransferase (in Japanese). Protein Nucleic Acid Enzyme 48: 2394-2403
2. Varki A. (1994) Selectin ligands. Proc. Natl. Acad. Sci. USA 91: 7390-7397
3. Kukowska-Latallo J. F., Larsen R. D., Nair R. P. and Lowe J. B. (1990) A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group (α1,3/1,4) fucosyltransferase. Genes Dev. 4: 1288-1303
4. Lowe J. B., Kukowska-Latallo J. F., Nair R. P., Larsen R. D., Marks R. M., Marcher B. A. et al. (1991) Molecular cloning of a human fucosyltransferase gene that determines expression of the Lewis X and VIM-2 epitopes but not ELAM-1-dependent cell adhesion. J. Biol. Chem. 266: 17467-17477
5. Weston B. W., Nair R. P., Jarsen R. D. and Lowe J. B. (1992) Isolation of a novel human α1,3 fucosyltransferase gene and molecular comparison to the human Lewis blood group α(1,3/1,4) fucosyltransferase gene, synthetic, homologous, nonallelic genes encoding enzymes with distinct acceptor substrate specificity. J. Biol. Chem. 267: 4152-4160
6. Weston B. W., Smith P. L., Kelly R. J. and Lowe J. B. (1992) Molecular cloning of a fourth member of a human α(1,3) fucosyltransferase gene family: multiple homologous sequences that determine expression of the Lewis X, sialyl Lewis X, and difucosyl sialyl Lewis X epitopes. J. Biol. Chem. 267: 24575-24584
7. Sasaki K., Kurata K., Funayama K., Nagata M., Watanabe E., Ohta S. et al. (1994) Expression cloning of a novel α1,3-fucosyltransferase that is involved in biosynthesis of the sialyl Lewis X carbohydrate determinants in leukocytes. J. Biol. Chem. 269: 14730-14737
8. Kudo K., Ikehara Y., Togayachi A., Kaneko M., Hiraga T., Sasaki K. et al. (1998) Expression, cloning and characterization of a novel murine α1,3-fucosyltransferase, mFuc-TIX, that synthesises the Lewis X (CD15) epitope in brain and kidney. J. Biol. Chem. 273: 26729-26738
9. Hakomori S. I. (1996) Tumor malignancy defined by aberrant glycosylation and sphingo (glyco) lipid metabolism. Cancer Res. 56: 5309-5318
10. Liu F., Qi H. L., Zhang Y., Zhang X. Y. and Chen H. L. (2001) Transfection of c-erbB2/neu gene up-regulates the expression of sialyl Lewis X, α1,3 fucosyltransferase VII and metastatic potential in human hepatocarcinoma cell line. Eur. J. Biochem. 268: 3501-3512
11. Liu F., Qi H. L. and Chen H. L. (2001) Regulation of differentiation- and proliferation inducers on Lewis antigens, α-fucosyltransferase and metastatic potential in hepatocarcinoma cells. Br. J. Cancer 84: 1556-1563
12. Liu F., Zhang Y., Zhang X. Y. and Chen H. L. (2002) Transfection of nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, α1,3 fucosyl-transferase VII and metastatic potential. J. Cancer Res. Clin. Oncol. 128: 189-196
13. Nakamori S., Kameyama M., Imaoka S., Furakawa H., Ishikawa O., Sasaki T. et al. (1993) Increased expression of sialyl Lewis X antigen correlates with poor survival in patients with colorectal carcinoma: clinico-pathological and immunohistochemical study. Cancer Res. 53: 3632-3637
14. Jorgensen T., Berner A., Kaalhus O., Tveter K. J., Danielsen H. E. and Bryne M. (1995) Up-regulation of the oligosaccharide sialyl Lewis X: a new prognosis parameter in metastatic prostate cancer. Cancer Res. 55: 1817-1819
15. Ogawa J., Tsurumi T., Yamada S., Koide S. and Shohtsu A. (1994) Blood vessel invasion and expression of sialyl Lewis X and proliferating cell nuclear antigen in non-small cell lung cancer. Cancer 73: 1177-1183
16. Quo H. B., Jiang A. L., Ju T. Z. and Chen H. L. (2000) Opposing changes in N-acetylglucosaminyltransferase-V and III during the cell cycle and all-trans retinoic acid treatment of hepatocarcinoma cell line. Biochim. Biophys. Acta 1495: 297-307
17. Knudsen K. E., Arden K. C. and Cavence W. K. (1998) Multiple G1 regulatory elements control the androgen-dependent proliferation of prostate carcinoma cells. J. Biol. Chem. 273: 20213-20222
18. Guo P., Zhang Y., Shen Z. H., Zhang X. Y. and Chen H. L. (2004) Effect of N-acetylglucosaminyltransferase V on the expressions of other glycosyltransferases. FEBS Lett. 562: 93-98
19. Takano Y., Kato Y., Diest P. J. van, Masuda M., Mitomi H. and Okayasu I. (2000) Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am. J. Pathol. 156: 585-594
20. Kudo T., Ikehara Y., Togayachi A., Morozumi K., Watanabe M., Nakamura M. et al. (1998) Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. Lab. Invest. 78: 797-811
21. Sherr C. J. (1993) Mammalian G1 cyclins. Cell 73: 1059-1065
22. Sherr C. J. (2000) The Pezcoller Lecture: Cancer cell cycles revisited. Cancer Res. 60: 3689-3695
23. Ruas M. and Peters G. (1998) The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta Cancer Rev. 1378: F115-F177
24. Sherr C. J. and Roberts J. M. (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9: 1149-1163
25. Polyak K., Lee M. H., Erdjument-Bromage H., Koff A., Roberts J. M., Tempst P. et al. (1994) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66
26. Molinari M. (2000) Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif. 33: 261-274
27. Narita Y., Nagane M., Mishima K., Su Huang H. J., Furnari F. B. and Cavenee W. K. (2002) Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas. Cancer Res. 62: 6764-6769
28. Collado M., Medema R. H., Garcia-Cao I., Dubuisson M. L., Barradas M., Glassford J. et al. (2000) Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip 1. J. Biol. Chem. 275: 21960-21968
29. Cheng M., Sexl V., Sherr C. J. and Roussel M. F. (1998) Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. USA. 95: 1091-1096
30. Naumann U., Weit S., Rieger L., Meyermann R. and Weller M. (1999) p27 modulates cell cycle progression and chemosensitivity in human malignant glioma. Biochem. Biophys. Res. Commun. 261: 890-896
31. 3 gets its message across. Science 277: 254
32. Pang L., Sawada T., Decker S. J. and Saltiel A. R. (1995) Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270: 13585-13588